Download PDF

Other users also viewed these articles

Surveillance and management of hepatocellular carcinoma after treatment of hepatitis C with direct-acting antiviral drugs Caiyun Yang; Fengxiang Lv; Jiaqi Yang; Dawei Ding; Lina Cui; Ying Han;
10.1016/j.aohep.2024.101582
Clinical usefulness of an ultra-high-sensitivity hepatitis B surface antigen assay to determine the cessation of treatment for HBV reactivation Takanori Suzuki; Akihiro Tamori; Kentaro Matsuura; Takako Inoue; Shigeru Kusumoto; Shinya Hagiwara; Haruka Sagi; Atsushi Kaneko; Shuko Murakami; Hayato Kawamra; Kei Fujiwara; Katsumi Aoyagi; Masaru Enomoto; Ritsuzo Kozuka; Hiromi Kataoka; Yasuhito Tanaka;
10.1016/j.aohep.2024.101764
Direct-acting antiviral agents and risk of Hepatocellular carcinoma: Critical appraisal of the evidence Ciro Celsa; Caterina Stornello; Paolo Giuffrida; Carmelo Marco Giacchetto; Mauro Grova; Gabriele Rancatore; Concetta Pitrone; Vito Di Marco; Calogero Cammà; Giuseppe Cabibbo;
Ann Hepatol. 2022;27 Supl 1: